GATC Health to Speak at the Opioid Settlement Abatement Summit in Washington DC

GATC to highlight its AI-driven addiction solutions to a national audience attending to learn how to allocate the tens of billions of dollars resulting from opioid abatement settlements for states, counties, municipalities and tribes; Dr. Rahul Gupta, director of the Office of National Drug Control Policy,will be the keynote speakers

IRVINE, Calif., Jan. 24, 2023 /PRNewswire/ -- GATC Health Corp, a science and technology company revolutionizing drug discovery and disease prediction using artificial intelligence (AI), today announced that Tyrone Lam, COO of GATC Health, will present the company's fentanyl abatement drug candidates that were identified by GATC's AI-based drug discovery and development platform. The novel created by GATC are currently in preclinical drug evaluation studies. Guidelines allocated a portion of the Opioid Abatement Settlement funds for research and development, which includes GATC's opioid addiction abatement projects.

GATC will present AI-driven addiction solutions to a national audience of states, counties, municipalities and tribes

The allocation of opioid settlement funds to states has already begun, yet many states are lagging in their efforts to organize an adequate abatement plan or council to direct and oversee the distribution. The Opioid Settlement Abatement SummitModel Guidance for States, Counties, Municipalities and Tribes will take place on Thursday January 26th, 2023at Georgetown University and virtually, and focus on providing model abatement guidance for states, counties, municipalities and tribes to effectively plan for, implement and track opioid settlement funds.The goal of the event is to highlight effective programs, initiatives and tools that are easily adopted and should be considered in state abatement plans as funding begins to come in.